CRISPRi Maps 6,500 Essential Gene Interactions in TB, Uncovering Drug Pair Targets
Updated
Updated · Nature.com · Nov 4
CRISPRi Maps 6,500 Essential Gene Interactions in TB, Uncovering Drug Pair Targets
2 articles · Updated · Nature.com · Nov 4
Summary
Researchers built a dual-sgRNA CRISPRi platform that mapped essential-gene interactions in Mycobacterium tuberculosis, producing nearly 6,500 interactions and a parallel map of about 8,500 in M. smegmatis.
The system screened roughly 2.2 million sgRNA permutations in M. tuberculosis and 2.3 million in M. smegmatis, overcoming earlier limits that largely excluded essential genes and many antibiotic targets.
The maps recovered known biology, linked thousands of previously unrecognized gene pairs, and highlighted functional clusters across pathways such as cell wall synthesis, folate metabolism and the electron transport chain.
AlphaFold3 analysis of about 600,000 gene pairs predicted 15,240 candidate protein interactions, while follow-up experiments validated new respiratory genes and several synergistic or antagonistic drug combinations.
The study provides the first comprehensive essential-gene interaction map for M. tuberculosis, offering a public resource to guide TB target discovery, combination therapy design and future pathogen-wide interaction mapping.
How might combining AlphaFold3 with CRISPRi screening revolutionize our ability to defeat other drug-resistant superbugs beyond tuberculosis?
Can inhibiting the Pks13 enzyme truly unlock a new era of ultra-potent, synergistic tuberculosis treatments in human patients?
Will these newly mapped bacterial vulnerabilities hold up against the unpredictable evolutionary pressures of a real-world human infection?
Dual-CRISPRi Mapping of 6,500 Essential Gene Interactions in Mycobacterium tuberculosis: A New Era for Rational TB Drug Design and Global Health
Overview
Researchers at Rockefeller University overcame a major barrier in tuberculosis research by developing a dual-gene CRISPR interference (CRISPRi) platform that can suppress two essential genes in Mycobacterium tuberculosis without killing the bacteria. This allowed them to systematically map nearly 6,500 genetic interactions among 762 essential genes, creating the most comprehensive interaction map in any pathogen. By combining these maps with AlphaFold 3 structural predictions, they identified direct protein-protein associations and clarified the roles of previously mysterious genes. The approach also enabled the rational design of synergistic antibiotic combinations, including new drug pairings that enhance treatment and help avoid ineffective combinations, paving the way for faster, targeted TB therapies.